Search Results 671-680 of 17151 for Birth Control Evolution

  1. Vaccine requirements and vaccine research highlights

    A U.S. national initiative called Healthy People 2020 makes goals regarding vaccination and infectious disease control, among other goals. This has been ...

  2. News - Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery - Mayo Clinic Research

    News about the Mayo Clinic Kern Center for the Science of Health Care Delivery covers COVID-19, surgical research, pain management and opioids, ...

  3. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

    * Male subjects and female subjects of childbearing potential (FOCBP) agree to use highly effective contraception measures from the time of first dose of ...

  4. Pediatrics Clinical Trials - Medical Professionals

    A Study of the Effects of Preterm Birth on Lung Disease and Innate Immunity Later in Life. Rochester, Minn. The primary purpose of this study is to ...

  5. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

    About this study. The purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of ...

  6. Perimenopause - Doctors and departments - Mayo Clinic

    Mayo Clinic's experts continue to innovate in the diagnosis and treatment of obstetric and gynecologic conditions, including care during perimenopause. The ...

  7. Experiential Pharmacogenomic Education for Providers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Evaluation of Immunophenotype Signatures in Hypereosinophilia-Associated Disorders - Mayo Clinic

    The purpose of this study is to characterize the immunophenotype of individuals with hypereosinophilia-associated cardiovascular, gastrointestinal, hematologic, ...

  9. A Study of PROQOL (Patient Reported Outcome Quality of Life) Tool in the Hematology and Oncology Population - Mayo Clinic

    A Study of PROQOL (Patient Reported Outcome Quality of Life) Tool in the Hematology and Oncology Population · Overview · Participation eligibility · Participating ...

  10. Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Women of childbearing potential who do not agree to practice 2 different methods of birth control or remain abstinent during the trial and for 30 days after the ...